Skip to main content

Select Drug Profiles

Essential Health Benefits, Comparative Effectiveness Research, Payment Models All Play a Role in the ACA

Assessing the Value of New, Costly Radiation Therapies in Older Patients with Breast Cancer

Caroline Helwick

Variations in Cancer Treatment Raise Average Cost of Care by $25,000 per Patient

Can We Afford to Make Progress in Cancer Care?

Caroline Helwick

Nearly 1 in 5 Patients with Cancer Reports Financial Distress

Do Financial Incentives Drive Physician Behavior?

Caroline Helwick

Specialty Pharmaceuticals Update

David B. Nash, MD, MBA

Implications of the Employer Mandate Delay on the Healthcare Marketplace

Kip Piper, MA, FACHE, F. Randy Vogenberg, PhD, FASHP

Practice Management

Real-World Corticosteroid Utilization Patterns in Patients with Metastatic Castration-Resistant Prostate Cancer in 2 Large US Administrative Claims Databases

Marie-Hélène Lafeuille, MA, Jonathan Gravel, MSc, Amanda Grittner, MA, Patrick Lefebvre, MA, Lorie A. Ellis, PhD, Scott McKenzie, MD

Stakeholder Perspective

“Roid Rage”

by Atheer A. Kaddis, PharmD

Original Research

Perspectives of Quality Care in Cancer Treatment: A Review of the Literature

Lisa M. Hess, PhD, Gerhardt Pohl, PhD

Stakeholder Perspective

Quality of Cancer Care: Emerging Definition and Measurements, but Reimbursement Lagging

by Craig K. Deligdish, MD

Page 174 of 244
Results 1731 - 1740 of 2434